Talking Rheumatology Research
Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.
Episodes
47 episodes
Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis
Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients. Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care ...
•
Episode 47
•
10:32
Ep 46. Patient involvement in Rheumatology research
Peter Boyd and Ingrid de Groot join Dr. Latika Gupta to explore the value of patient involvement in Rheumatology research. Reflecting on their lived experience, Peter and Ingrid discuss their proudest moments, and identify areas in the patient ...
•
21:25
Ep 45. Community awareness of childhood arthritis in the UK
Recorded at #BSR24, Richard P Beesley joins Dr Ai Lyn Tan to discuss his recent article, which measured the level of community awareness in the UK that children and young people can develop arthritis.Listen now to hear about what you can...
•
9:34
Ep 44. Neuropsychiatric symptoms in systemic autoimmune rheumatic diseases
In this fascinating episode recorded at #BSR24, Dr Melanie Sloan joins Prof Ernest Choy to discuss the latest results from the INSPIRE study, which seeks to understand neuropsychiatric symptom prevalence and impact in people with systemic autoi...
•
Episode 44
•
12:34
Ep. 43 The metaverse: a new frontier for rheumatology
Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients.Listen now to hear about the current technological develop...
•
11:16
Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?
Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combina...
•
17:53
Ep 41. Addressing the leaky pipeline
What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of w...
•
17:56
Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy
We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's kee...
•
4:41
Ep 39. UK JIA Biologics Register: stopping biologics for remission
What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is ...
•
10:06
Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study
Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate respons...
•
Episode 38
•
7:19
Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes?
Anika Hoque joins Dr Michael Backhouse to discuss their recent article, which examines the construct validity of the RA foot disease activity index in relationship to musculoskeletal ultrasonography and clinical examination.Listen now to...
•
Episode 37
•
12:45
Ep 36. Trainee Publishing Programme 2023: Dr Charlotte Sharp & Karen Staniland
Can patients with rheumatoid arthritis examine their own joints? Dr David Liew talks to Dr Charlotte Sharp and Karen Staniland about their work to create a video teaching patients how to self-examine tender and swollen joint...
•
19:03
Ep 35. Trainee Publishing Programme 2023: Dr Pallavi Shamdasani
How can we best diagnose septic arthritis in the acute care setting? Dr Pallavi Shamdasani joins Prof Rene Westhovens to discuss the utility of synovial aspiration and intra-operative synovial fluid and tissue culture for the acc...
•
Episode 35
•
18:07
Ep 34. Trainee Publishing Programme 2023: Dr Shivani Gor & Dr Sung-Hee Kim
What is the relationship between COVID-19 vaccination and disease flares in patients with inflammatory arthritis (IA)? Dr Shivani Gor and Dr Sung-Hee Kim join Dr Mwidimi Ndosi to discuss their retrospective study, which used C-re...
•
Episode 34
•
16:34
Ep 33. Trainee Publishing Programme 2023: Dr Lauren Huckerby
What evidence is there for effective transitional care in young people with chronic pain, and what should ideal transitional care look like? Dr Lauren Huckerby joins Dr Diederik De Cock to discuss her recent systematic review - o...
•
Episode 33
•
16:18
Ep 32. Trainee Publishing Programme 2023: Dr Cristiana Sieiro Santos
Can we classify the clinical phenotype of systemic sclerosis by autoantibodies? Dr Cristiana Sieiro Santos joins Dr Anastasia Madenidou to discuss her recent article - one of the winning papers from the 2023 Rheumatology Adva...
•
Episode 32
•
11:22
Ep 31. Are AAV patients at an increased risk of stroke?
Dr Aladdin J Mohammad joins Dr Marwan Bukhari to discuss their article, chosen as the August Editor's Choice article, which determines the incidence rate, predictors and outcome of stroke in a population-based cohort of individuals with ANCA-as...
•
Episode 31
•
8:18
Ep 30. Diagnosing cocaine-induced vasculitis
How can you differentiate between cocaine-induced and ANCA-associated vasculitis? Dr Sander van Leuven joins Dr David Liew to discuss a recent case series analysis from centres in Birmingham and London. Sander is a consultant rheumatolo...
•
Episode 30
•
12:34
Ep 29. Does vaccination against SARS-CoV-2 infection cause adverse events among SLE patients?
Dr Ioannis Parodis and Dr Elena Nikiphorou join Dr Eunice Co to discuss their findings in the COVAD study of the safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus. Listen now to hear the ...
•
Episode 29
•
14:21
Ep 28. Does ultrasound-defined tenosynovitis and synovitis aid the prediction of persistent arthritis?
Dr Ilfita Sahbudin joins Dr Marwan Bukhari to discuss the value of ultrasound-defined tenosynovitis and synovitis in the prediction of persistent arthritis in an inception cohort of DMARD-naive patients with early arthritis. Listen now to hear ...
•
Season 1
•
Episode 28
•
8:12
Ep 27. Is secukinumab safe and effective in ankylosing spondylitis?
Do real-world data demonstrate that secukinumab is safe and effective for use in ankylosing spondylitis? Dr Adeola Ajibade joins Dr Ai Lyn Tan to discuss her recent paper - a multicentre, retrospective record-based review of the efficacy and sa...
•
Episode 27
•
13:39
Ep 26. Dr Polly Livermore and Heather Rostron discuss their future research plans
Dr Polly Livermore (Great Ormond Street Hospital, UK) and Heather Rostron (Leeds Children’s Hospital, UK) join Caroline Groves to discuss their future research plans to improve clinical care and support processes for children, young people, and...
•
Episode 26
•
13:18
Ep 25. How does symptom duration before DMARD therapy impact the costs of RA?
Dr Ilfita Sahbudin (University of Birmingham, UK) joins Dr Ai Lyn Tan to discuss the relationship between symptom/disease duration and resource utilisation/costs following rheumatoid arthritis diagnosis.Want to read the full paper? Find ...
•
Episode 25
•
11:01
Ep 24. Risk of myocardial infarction among RA patients receiving IL6 or TNF inhibitors
British Society for Rheumatology Young Investigator Award winner Dr Zixing Tian (University of Manchester, UK) joins Dr Steven Zhao to discuss the work behind the winning abstract 'No difference in risk of myocardial infarction among patients r...
•
Season 1
•
Episode 24
•
12:26
Ep 23. The long-term use of tocilizumab in giant cell arteritis
Dr Sean Gill and Dr Chetan Mukhtyar (Norfolk and Norwich University Hospital, UK) discuss the efficacy of tocilizumab for GCA, based on a 12-month extension of Stone et al.’s landmark clinical trial. Dr Mukhtyar provides an overview of the tria...
•
13:28